Birth Control Pills Recalled Due to Effectiveness Concerns

The FDA alerted thousands of women about the potential ineffectiveness of Tydemy birth control pills

Screen Shot 2022 04 18 At 2 42 14 Pm
Getty Images

According to a recent CBS News article, the FDA issued a warning about the recall of thousands of Tydemy brand birth control pills by Lupin Pharmaceuticals due effectiveness concerns. The recall is based on Lupin's own testing, which found that two specific batches of the pills may have decreased effectiveness in preventing pregnancy. The affected products were distributed nationwide from June 2022 to May 2023, totaling 4,179 boxes or approximately 350,000 tablets.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?